Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Miguel Ángel Vesga
University of the Basque Country - Biocruces Bizkaia Health Research Institute
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
32
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Phase I, Dose-Escalation Clinical Trial to Evaluate the Safety of Infusing Natural Killer Cells as Adoptive Therapy in COVID-19: Release
Number of pages: 26
Posted: 14 Jun 2024
Clara Hernández-Blanco
,
Karima Al-Akioui-Sanz
,
Lara Herrera del Val
,
Cristina Aguirre-Portolés
,
Daniel Lozano-Ojalvo
,
Leticia Pérez-Rodríguez
,
Jordi Ochando
,
Pilar Guerra-García
,
Alejandro Martín-Quirós
,
JL Vicario
,
Silvia Santos Cabrera
,
Miguel Ángel Pérez-Vaquero
, Miguel Ángel Vesga,
Alberto M Borobia
,
Antonio J. Carcas
,
A Balas
,
MA Moreno
,
Rebeca Pérez de Diego
,
M Gasior
,
Bernat Soria
,
Cristina Eguizabal Argaiz
and
A Pérez-Martínez
Hospital Universitario La Paz, Universidad de Alicante - Alicante’s Institute for Health and Biomedical Research (ISABIAL), University of the Basque Country - Biocruces Bizkaia Health Research Institute, Health Research Institute Hospital La Fe, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Mount Sinai Health System - Icahn School of Medicine, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Hospital Universitario La Paz, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, Centro de Transfusión de la Comunidad de Madrid, University of the Basque Country - Biocruces Bizkaia Health Research Institute, University of the Basque Country - Biocruces Bizkaia Health Research Institute, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Universitario La Paz - Servicio de Farmacología Clínica, La Paz Institute for Health Research (IdiPAZ), Centro de Transfusión de la Comunidad de Madrid, Centro de Transfusión de la Comunidad de Madrid, La Paz Institute for Health Research (IdiPAZ), Hospital Universitario La Paz, Miguel Hernández University of Elche - Pediatric Hemato-oncology Department, University of the Basque Country - Biocruces Bizkaia Health Research Institute and Hospital Universitario La Paz
Downloads
32
(1,290,922)
View PDF
Download
Abstract:
Cell therapyNatural Killer cellsmicrochimerimsSARS-CoV-2COVID-19Convalescent donorCytokines
Feedback